As I understand it, the company is making every effort to be listed on Canadian exchange, Indaflex likely will move forward, in the next few months the news likely will come out on the 3-products that were developed for the U.S. global pharma company and company is looking to move Vansolin and one other product into phase I/II by the end of the year. All looks good, clearly, one has to be patient. Only fools be selling their stock at 14 cents!!!!
Go AlphaRx!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!